Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
about
E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.Modulation of T cell cytokine production by interferon regulatory factor-4Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genesIRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latencyInterferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradationFunctional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoterDirect triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimersA novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytesPhosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domainThe histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsivenessHuman papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activityRegulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombinationInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesA novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genesLineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4)Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expressionThe IRF family, revisitedInterferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factorsDown-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionInterferon-regulatory factors determine macrophage phenotype polarizationStructure of IRF-1 with bound DNA reveals determinants of interferon regulationSPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1Physical and functional interactions between the transcription factor PU.1 and the coactivator CBPInteraction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosomeInterferon consensus sequence-binding protein is constitutively expressed and differentially regulated in the ocular lensPU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 geneAKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domainMultiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific mannerExpression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanAIdentification of amino acid residues in the ETS transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formationPossible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemiaThe transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrbDevelopment of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-BDisabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion.A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexesInterferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction
P2860
Q24301680-55690D00-E157-4D83-8249-F240F8D6A0D6Q24310642-3557D572-EC7B-494B-9F34-C6E60B8FB35AQ24311045-3DFCDDA6-FC59-475E-9435-14DF2C9BE4F7Q24315695-5C5AC546-38A6-49CC-8FDA-5CFAFB69B185Q24522348-EA5EA05D-C993-4D28-8331-558D47CB5E6CQ24523761-543D5B22-0581-4663-BBAD-C5D9CE9938C4Q24533137-75059F02-DDC8-406D-9543-CBCE77314A38Q24533140-ABEB8437-BFC6-442D-86A5-F07CC1EBA46AQ24533589-C47FA48D-AD20-4F5E-A6B8-77D3ED9A8EBEQ24537405-2A699C5D-D8F6-4BD9-9F60-C048E0C011F4Q24537686-6953F114-D4ED-498F-9403-003775190A00Q24551074-7E8B35AA-81AA-407A-A05D-CB5A0C6EC6F4Q24554528-401CA538-8BB9-41CB-A59F-E74C51245D02Q24599944-FB320559-998D-4FCB-BD3E-DDEC64436053Q24633098-D18DEAEC-29B0-4BB5-90B9-5F7DEE6D33ADQ24646670-58AF5BC3-88D5-4AAC-AB35-5E00641183CFQ24650588-BBDF7FD9-CEB2-4E6C-B8F2-EF4A1BD7B70EQ24671741-344CE7D8-6DDF-4A22-83CE-2CC61FF4DA11Q24673747-7C81626B-0764-479F-A463-9CF8EA6983EFQ24674526-A66FF994-AF77-43F2-8079-2531778A5629Q24678497-BD1E80B3-1D7F-4D1E-A230-D5FD500CA2DEQ24682160-129B883B-C95B-4F2F-8546-4EDE0D3655BFQ24810666-E66D383A-6EB1-4B53-8AE0-E52628175088Q27012493-C7BE50C4-E83B-437C-83F9-FFB4BFA5863DQ27748772-71C6AF59-648A-4723-B179-8B032EFA80ABQ28119191-2B7DAC97-7720-4816-9301-91331E46A6BFQ28137946-23C25678-1B77-4FD4-AB12-3285201E0501Q28138857-E32B07B3-C1F4-4489-9DC2-40EE75DE0CCEQ28139686-173069DD-9576-4A6C-94F6-EE33DEB74FCCQ28139719-4E2BB691-A802-4235-A666-ECB23B4635F1Q28141194-27E92968-78BF-4B54-8578-D44F4AE67E28Q28188832-A54F09B2-0D4C-4F99-A382-4CD844E0271DQ28201955-6B666497-779D-474D-88E6-0AEDB06A8850Q28208097-9792F81A-9BD3-47BC-A94D-AA335ED165A9Q28212275-E10E6A57-8A07-4296-850C-DDAB42266D44Q28278347-F92103F6-9AA4-46B7-B6BA-DBCDC3078B5EQ28293931-E95949FA-CDD6-47E0-8CCD-B59E94ACDEF1Q28508344-F7FA09BE-0743-4FCE-A62B-D073129655A6Q28508859-60AA24E3-BD51-46AD-98D4-4D576B1586E2Q28513103-AF19B7C9-EEF2-4016-8246-DEE92A389B5B
P2860
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Pip, a novel IRF family member ...... ent transcriptional activator.
@en
type
label
Pip, a novel IRF family member ...... ent transcriptional activator.
@en
prefLabel
Pip, a novel IRF family member ...... ent transcriptional activator.
@en
P2093
P356
P1433
P1476
Pip, a novel IRF family member ...... ent transcriptional activator.
@en
P2093
P304
P356
10.1101/GAD.9.11.1377
P577
1995-06-01T00:00:00Z